+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Seborrhoeic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Palmoplantar Pustulosis - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Pustulosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Palmoplantar Keratoderma - Pipeline Insight, 2025 - Product Thumbnail Image

Palmoplantar Keratoderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2025 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Chronic Hand Eczema - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hand Eczema - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Contact Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Xerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Xerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
Chronic Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pressure Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Pressure Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Impetigo - Pipeline Insight, 2025 - Product Thumbnail Image

Impetigo - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Pruritus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Chronic Urticaria Or Hives - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Urticaria Or Hives - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Severe Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more